Let’s start up with the current stock price of Onconova Therapeutics Inc. (ONTX), which is $0.66 to be very precise. The Stock rose vividly during the last session to $0.73 after opening rate of $0.7205 while the lowest price it went was recorded $0.6543 before closing at $0.72.
Recently in News on April 22, 2021, Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced today that the first patient has been dosed in an investigator-initiated Phase 2 study to assess the efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB)-associated locally advanced/metastatic squamous cell carcinoma (SCC). The patient was dosed at the EB House Austria, a center of expertise for epidermolysis bullosa at the University Hospital Salzburg, Austria. Additional sites are anticipated to be opened in the UK and in the US to study this rare and genomically driven devastating disease. You can read further details here
Onconova Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9300 on 02/18/21, with the lowest value was $0.4350 for the same time period, recorded on 01/04/21.
Onconova Therapeutics Inc. (ONTX) full year performance was 115.61%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Onconova Therapeutics Inc. shares are logging -65.65% during the 52-week period from high price, and 248.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $1.93.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 8305003 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Onconova Therapeutics Inc. (ONTX) recorded performance in the market was 42.34%, having the revenues showcasing -2.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 158.38M, as it employees total of 11 workers.
Market experts do have their say about Onconova Therapeutics Inc. (ONTX)
During the last month, 0 analysts gave the Onconova Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8438, with a change in the price was noted +0.3488. In a similar fashion, Onconova Therapeutics Inc. posted a movement of +111.01% for the period of last 100 days, recording 39,868,922 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ONTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Onconova Therapeutics Inc. (ONTX)
Raw Stochastic average of Onconova Therapeutics Inc. in the period of last 50 days is set at 7.43%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.55%. In the last 20 days, the company’s Stochastic %K was 31.81% and its Stochastic %D was recorded 35.20%.
Bearing in mind the latest performance of Onconova Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 42.34%. Additionally, trading for the stock in the period of the last six months notably improved by 150.19%, alongside a boost of 115.61% for the period of the last 12 months. The shares increased approximately by -13.90% in the 7-day charts and went up by -30.13% in the period of the last 30 days. Common stock shares were lifted by -2.36% during last recorded quarter.